ADIPOQ and thyroid gland carcinoma: Significantly decreased serum concentrations of adiponectin have been also demonstrated in most forms of thyroid carcinoma with papillary one in particular presumably due to indirect effects of adiponectin through regulation of insulin sensitivity and metabolism [181].